Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)

9 May 2025

Abstract excerpt

Assessing treatment response in neuroendocrine tumors (NET) remains a significant challenge due to their typically indolent growth and heterogenity, the frequent occurrence of disease stabilization rather than tumor shrinkage after therapy, and the inherent limitations of conventional imaging criteria. While molecular imaging-primarily somatostatin receptor (SST) PET/CT-has improved lesion detection, the absence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40345899
DOI: 10.1053/j.semnuclmed.2025.04.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)PMID 40345899Read ↗

The evolving landscape of neuroendocrine tumors.Semantic proximity Read ↗

Systemic Therapies for Metastatic Pancreatic Neuroendocrine Tumors.Semantic proximity Read ↗

Clinical Presentation and Diagnosis of Neuroendocrine Tumors.Semantic proximity Read ↗

Mixed neuroendocrine-non-neuroendocrine neoplasms of the digestive system: A mini-review.Semantic proximity Read ↗

Molecular and functional imaging in cancer-targeted therapy: current applications and future directionsSemantic proximity Read ↗

Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Advanced Neuroendocrine Tumours (NETs) in a Limited Resource EnvironmentSemantic proximity Read ↗

Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches.Semantic proximity Read ↗

Profiling proteomic responses in small intestinal neuroendocrine tumor GOT1 after [177Lu]Lu-DOTATATE therapySemantic proximity Read ↗

Prognostic and predictive biomarkers in neuroendocrine tumours.Semantic proximity Read ↗

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).Semantic proximity Read ↗

A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing-tumor as a potential target of peptide receptor imaging and therapySemantic proximity Read ↗

Systemic therapeutic strategies for GEP-NETS: what can we expect in the future?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.